﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2014v6.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2016-05-16T18:04:05-05:00</ReturnTs>
    <TaxPeriodEndDt>2015-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>043097400</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>KEVIN P MARTIN ASSOCIATES PC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>10 FORBES WEST</AddressLine1Txt>
        <CityNm>BRAINTREE</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02184</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2014-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>043045706</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>COMMUNITY RESEARCH INITIATIVE OF NEW ENGLAND INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>COMM</BusinessNameControlTxt>
      <PhoneNum>6175021744</PhoneNum>
      <USAddress>
        <AddressLine1Txt>38 CHAUNCY STREET NO 500</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02111</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JULIE K MARSTON</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>6175021744</PhoneNum>
      <SignatureDt>2016-05-16</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>THERESA J CREEDEN</PreparerPersonNm>
      <PTIN>P00747568</PTIN>
      <PhoneNum>7813803520</PhoneNum>
      <PreparationDt>2016-05-16</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2014</TaxYr>
    <BuildTS>2016-08-17 19:52:53Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="6">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>JULIE K MARSTON</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>38 CHAUNCY STREET SUITE 500</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02111</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>14821283</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.CRINE.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1989</FormationYr>
      <LegalDomicileStateCd>MA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>DEDICATED TO HIV AND HEPATITIS C CLINICAL RESEARCH, TREATMENT, EDUCATION, AND FINANCIAL ASSISTANCE FOR APPROVED HIV DRUG TREATMENTS AND HEALTH INSURANCE COVERAGE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>8</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>8</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>52</TotalEmployeeCnt>
      <TotalVolunteersCnt>91</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>16851769</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>14420586</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>95877</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>400697</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>0</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>0</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>16947646</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>14821283</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>0</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>2345982</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>2381574</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>207218</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>14640758</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>12606127</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>16986740</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>14987701</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-39094</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-166418</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>3062785</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3077097</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1847611</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>2028341</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>1215174</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>1048756</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>DEDICATED TO HIV AND HEPATITIS C CLINICAL RESEARCH, TREATMENT, EDUCATION, AND FINANCIAL ASSISTANCE FOR APPROVED HIV DRUG TREATMENTS AND HEALTH INSURANCE COVERAGE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>13246284</ExpenseAmt>
      <Desc>HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR, AND APPROXIMATELY THREE-QUARTERS OF HDAP CLIENTS HAVE INCOME S OF LESS THAN TWO-HUNDRED PERCENT OF THE FEDERAL POVERTY LEVEL. THE PROGRAM IS AMONG THE NATION'S MOST COMPLETE DRUG ASSISTANCE PROGRAMS FOR PEOPLE LIVING WITH HIV. CRI/HDAP STAFF ALSO PROVIDES ASSISTANCE TO BOTH PROVIDERS AND CLIENTS IN ACCESSING AND NEGOTIATING CHANGES IN INSURANCE AND ENTITLEMENT PROGRAMS, INCLUDING CHANGE BROUGHT ABOUT BY IMPLEMENTATION OF THE FEDERAL AFFORDABLE CARE ACT.HDAP: CRI ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' HIV DRUG ASSISTANCE PROGRAM (HDAP) PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO MORE THAN 8,000 CLIENTS IN NEED EACH YEAR. HDAP PROVIDES ACCESS TO CRITICAL HIV-RELATED MEDICATIONS AND HEALTH INSURANCE FOR ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. IN PROVIDING THESE SERVICES, HDAP PLAYS A CRUCIAL ROLE IN SERVING THE HEALTHCARE NEEDS OF A DIVERSE POPULATION: MORE THAN HALF OF THE HDAP ENROLLEES ARE FROM COMMUNITIES OF COLOR</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>533032</ExpenseAmt>
        <RevenueAmt>278928</RevenueAmt>
        <Desc>EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS THROUGHOUT THE REGION WITH OVER 100 OF THOSE PROGRAMS SERVING NEARLY 3,000 PROVIDERS WITHIN THE MASSACHUSETTS LOCAL PERFORMANCE SITE WITHIN THE MOST RECENT PROGRAM YEAR. NEAETC'S FOCUS ON INNOVATION ALSO RESULTED IN A NEW TEACHING MODEL CONNECTING 14 COMMUNITY HEALTH CENTERS THROUGHOUT MASSACHUSETTS WITH PROGRAM FACULTY LIVE VIA WEBCAST, MAKING INTERACTIVE DISCUSSIONS POSSIBLE - A MODEL NOW REPLICATED THROUGHOUT OTHER GEOGRAPHICAL AREAS.EDUCATION: THROUGH ITS PARTNERSHIP WITH THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL, CRI MANAGES THE MASS. LOCAL PERFORMANCE SITE OF THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER (NEAETC) TO PROVIDE EDUCATION, SKILLS-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. NEAETC DEVELOPED, ENROLLED AND COMPLETED OVER 1,000 PROGRAMS SERVING MORE THAN 9,000 PROVIDERS T</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>396856</ExpenseAmt>
        <RevenueAmt>121769</RevenueAmt>
        <Desc>COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE, AND HEALTHY LIVES. HAVING EXPANDED ITS SCOPE TO INCLUDE HEPATITIS C CLINICAL TRIALS AS PART OF ITS MISSION, CRI COMPLETD TWO PIVOTAL STUDIES ON HEPATITIS C DURING THIS PAST YEAR. CRI HAS INITIATED MORE THAN FIFTY OF ITS OWN INNOVATIVE PHYSICIAN-LED RESEARCH STUDIES THAT CONTINUE TO PLAY A CRITICAL ROLE IN SHAPING THE EFFECTIVENESS OF HIV TREATMENT. CRI HAS DONE THIS WORK IN COLLABORATION WITH A RESEARCH NETWORK LINKING OVER 25 OTHER COMMUNITY-BASED CLINICAL TRIALS SITES THROUGHOUT THE UNITED STATES AS WELL AS TRIALS SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH. FINALLY, CRI'S PHYSICIAN/RESEARCHERS PRESENT CLINICAL RESEARCH TRIAL DATA TO RESEARCHERS AND PEOPLE WITH HIV AT INTERNATIONAL CONFERENCES THROUGHOUT THE YEAR.COMMUNITY-BASED RESEARCH: CRI PROVIDES CLINICAL TRIAL</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>14176172</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>0</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>52</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>8</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>8</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>1</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>0</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>0</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>THE CORPORATION</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>6175021744</PhoneNum>
        <USAddress>
          <AddressLine1Txt>38 CHAUNCY STREET SUITE 500</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02111</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>SMB PARTNERS T HOLMAN PHD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN B GOODE</PersonNm>
        <TitleTxt>VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SCOTT SILVIO</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL MORENO</PersonNm>
        <TitleTxt>CLERK</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN WDEVLIN PHARMD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALFREDO HERNANDEZ</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA A PINTCHMAN ROGERS</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANN WEBSTER PHD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SUSAN ULRICH JD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JULIE K MARSTON</PersonNm>
        <TitleTxt>EXEC DIR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>150518</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>30815</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CRAIG WELLS</PersonNm>
        <TitleTxt>DEPUTY DIR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>113891</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>7007</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>264409</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>37822</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>SMB PARTNERS LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>72 MEDWAY STREET</AddressLine1Txt>
            <CityNm>NORFOLK</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02056</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>PATIENT/DRUG DATABASE MAINTENANCE AND DE</ServicesDesc>
        <CompensationAmt>102792</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>JOHN LEONARD EMPLOYMENT SERVICES</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>75 FEDERAL STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02110</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>TEMPORARY STAFF HDAP PROGRAM</ServicesDesc>
        <CompensationAmt>101702</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>2</CntrctRcvdGreaterThan100KCnt>
      <GovernmentGrantsAmt>14033619</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>386967</AllOtherContributionsAmt>
      <TotalContributionsAmt>14420586</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>CONTRACTED SERVICE FEES</Desc>
        <BusinessCd>621500</BusinessCd>
        <TotalRevenueColumnAmt>278928</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>278928</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>CLASS FEES</Desc>
        <BusinessCd>621500</BusinessCd>
        <TotalRevenueColumnAmt>121769</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>121769</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>400697</TotalProgramServiceRevenueAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>14821283</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>400697</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </TotalRevenueGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>158333</TotalAmt>
        <ManagementAndGeneralAmt>158333</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>1806313</TotalAmt>
        <ProgramServicesAmt>1474388</ProgramServicesAmt>
        <ManagementAndGeneralAmt>185784</ManagementAndGeneralAmt>
        <FundraisingAmt>146141</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>163598</TotalAmt>
        <ProgramServicesAmt>129153</ProgramServicesAmt>
        <ManagementAndGeneralAmt>21643</ManagementAndGeneralAmt>
        <FundraisingAmt>12802</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>253330</TotalAmt>
        <ProgramServicesAmt>190873</ProgramServicesAmt>
        <ManagementAndGeneralAmt>43538</ManagementAndGeneralAmt>
        <FundraisingAmt>18919</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>13500</TotalAmt>
        <ManagementAndGeneralAmt>13500</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>450388</TotalAmt>
        <ProgramServicesAmt>377530</ProgramServicesAmt>
        <ManagementAndGeneralAmt>67314</ManagementAndGeneralAmt>
        <FundraisingAmt>5544</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>1930</TotalAmt>
        <ProgramServicesAmt>1698</ProgramServicesAmt>
        <ManagementAndGeneralAmt>26</ManagementAndGeneralAmt>
        <FundraisingAmt>206</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>156863</TotalAmt>
        <ProgramServicesAmt>96080</ProgramServicesAmt>
        <ManagementAndGeneralAmt>47857</ManagementAndGeneralAmt>
        <FundraisingAmt>12926</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>42248</TotalAmt>
        <ProgramServicesAmt>38901</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1414</ManagementAndGeneralAmt>
        <FundraisingAmt>1933</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>314759</TotalAmt>
        <ProgramServicesAmt>277895</ProgramServicesAmt>
        <ManagementAndGeneralAmt>30693</ManagementAndGeneralAmt>
        <FundraisingAmt>6171</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>21237</TotalAmt>
        <ProgramServicesAmt>19897</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28</ManagementAndGeneralAmt>
        <FundraisingAmt>1312</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>55097</TotalAmt>
        <ProgramServicesAmt>54352</ProgramServicesAmt>
        <ManagementAndGeneralAmt>123</ManagementAndGeneralAmt>
        <FundraisingAmt>622</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>22848</TotalAmt>
        <ProgramServicesAmt>22461</ProgramServicesAmt>
        <ManagementAndGeneralAmt>387</ManagementAndGeneralAmt>
      </InterestGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>31226</TotalAmt>
        <ManagementAndGeneralAmt>31226</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>28530</TotalAmt>
        <ProgramServicesAmt>25690</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2272</ManagementAndGeneralAmt>
        <FundraisingAmt>568</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>HEALTH INSURANCE - CLIE</Desc>
        <TotalAmt>5965489</TotalAmt>
        <ProgramServicesAmt>5965489</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DRUG REIMBURSEMENT</Desc>
        <TotalAmt>5445308</TotalAmt>
        <ProgramServicesAmt>5445308</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>FOOD</Desc>
        <TotalAmt>30189</TotalAmt>
        <ProgramServicesAmt>29942</ProgramServicesAmt>
        <ManagementAndGeneralAmt>173</ManagementAndGeneralAmt>
        <FundraisingAmt>74</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>LAB FEES</Desc>
        <TotalAmt>23835</TotalAmt>
        <ProgramServicesAmt>23835</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>2680</TotalAmt>
        <ProgramServicesAmt>2680</ProgramServicesAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>14987701</TotalAmt>
        <ProgramServicesAmt>14176172</ProgramServicesAmt>
        <ManagementAndGeneralAmt>604311</ManagementAndGeneralAmt>
        <FundraisingAmt>207218</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>764967</BOYAmt>
        <EOYAmt>602273</EOYAmt>
      </CashNonInterestBearingGrp>
      <AccountsReceivableGrp>
        <BOYAmt>1618722</BOYAmt>
        <EOYAmt>1926977</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>571179</BOYAmt>
        <EOYAmt>471156</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>267168</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>190477</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>107917</BOYAmt>
        <EOYAmt>76691</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <TotalAssetsGrp>
        <BOYAmt>3062785</BOYAmt>
        <EOYAmt>3077097</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>832038</BOYAmt>
        <EOYAmt>1026827</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>8614</BOYAmt>
      </DeferredRevenueGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>1006959</BOYAmt>
        <EOYAmt>1001514</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1847611</BOYAmt>
        <EOYAmt>2028341</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>1215174</BOYAmt>
        <EOYAmt>1048756</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>1215174</BOYAmt>
        <EOYAmt>1048756</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>3062785</BOYAmt>
        <EOYAmt>3077097</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-166418</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>1</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>1</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>22076797</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>21754819</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>18187334</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>16851769</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>14420586</CurrentTaxYearAmt>
        <TotalAmt>93291305</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>22076797</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>21754819</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>18187334</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>16851769</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>14420586</CurrentTaxYearAmt>
        <TotalAmt>93291305</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>93291305</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>2212</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>204</CurrentTaxYearMinus3YearsAmt>
        <TotalAmt>2416</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus2YearsAmt>4900</CurrentTaxYearMinus2YearsAmt>
        <TotalAmt>4900</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>93298621</TotalSupportAmt>
      <PublicSupportCY170Pct>0.99990</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.99990</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>62962</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>26263</DepreciationAmt>
        <BookValueAmt>36699</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>204206</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>164214</DepreciationAmt>
        <BookValueAmt>39992</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>76691</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>14821283</TotalRevEtcAuditedFinclStmtAmt>
      <RevenueNotReportedAmt>0</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>14821283</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>14821283</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>14987701</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>14987701</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>14987701</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>GAAP PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. FOR THOSE BENEFITS TO BE RECOGNIZED, A TAX POSITION MUST BE MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. FOR THE YEAR ENDED JUNE 30, 2015, THE AGENCY HAS DETERMINED THAT IT HAS NOT TAKEN ANY TAX POSITIONS WHICH WOULD RESULT IN AN UNCERTAINTY REQUIRING RECOGNITION IN THE ACCOMPANYING FINANCIAL STATEMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JULIE K MARSTON</PersonNm>
        <TitleTxt>EXEC DIR</TitleTxt>
        <BaseCompensationFilingOrgAmt>150518</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>23000</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>7815</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>181333</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>COMMUNITY RESEARCH INITIATIVE OF NEW ENGLAND, INC. HAS CONTRACTS WITH A SERVICE BUREAU TO PROVIDE MANAGEMENT AND ADMINISTRATIVE SERVICES TO INDIVIDUALS ELIGIBLE FOR COVERAGE UNDER THE MASSACHUSETTS HIV DRUG ASSISTANCE PLAN (HDAP). PROCESSING FEES ARE BASED ON VARIOUS RATES PER CLAIM OR DRUG TYPE. THE AGREEMENT IS FOR A ONE YEAR PERIOD WITH AUTOMATIC ONE-YEAR RENEWALS UNLESS TERMINATED IN WRITING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>IRS FORM 990 IS REVIEWED WITH THE DIRECTOR OF FINANCE. THE EXECUTIVE DIRECTOR AND THE TREASURER REVIEW WITH THE BOARD FINANCE COMMITTEE PRIOR TO APPROVAL AND SUSBMISSION. A PDF COPY IS PROVIDED TO ALL BOARD MEMBERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION REQUIRES ANNUAL DISCLOSURE OF CONFLICTS OR LACK OF CONFLICTS OF INTEREST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>COMPENSATION OF THE EXECUTIVE DIRECTOR IS REVIEWED AND APPROVED ANNUALLY BY THE BOARD OF DIRECTORS DURING THE BUDGET APPROVAL ACTIVITIES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>AVAILABLE AT THE MASSACHUSETTS SECRETARY OF STATE WEBSITE AND UPON WRITTEN REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>NO CHANGE IN PROCESS PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>